sponsored
PatientsVille.com Logo

PatientsVille

Azithromycin and Flagyl

Compare Side Effects

% of total side effects reported by users. DISCLAIMER: ALL DATA PROVIDED AS-IS. Data Source: openfda.gov.
Side EffectAzithromycinFlagyl
DIARRHOEA2.7% 3.6%
NAUSEA3.2% 3.4%
PAIN3.3% 2.3%
DYSPNOEA3.2% 2%
DRUG HYPERSENSITIVITY1.4% 3.2%
VOMITING2.5% 2.7%
PYREXIA2% 2.6%
DRUG INEFFECTIVE1.9% 2.4%
PNEUMONIA2.3% 1.2%
ANXIETY2.2% 1.5%
HEADACHE1.8% 2%
ABDOMINAL PAIN1.6% 2%
INJURY2% 1%
FATIGUE1.9% 1.9%
DIZZINESS1.8% 1.9%
PULMONARY EMBOLISM1.8% 0.8%
COUGH1.8% 0.7%
RASH1.5% 1.7%
ASTHENIA1.6% 1.5%
DRUG INTERACTION1.6% 1.2%
MALAISE1.4% 1.4%
DEEP VEIN THROMBOSIS1.4% 0.7%
HYPOTENSION1.2% 1.3%
ANAEMIA1.2% 1.3%
CHEST PAIN1.3% 0.9%
WEIGHT DECREASED1.2% 1.1%
DEPRESSION1.2% 1%
ABDOMINAL PAIN UPPER1.2% 1%
PRURITUS1% 1.2%
EMOTIONAL DISTRESS1.2% 0.6%
CONFUSIONAL STATE0.6% 1.2%
SEPSIS0.6% 1.2%
PAIN IN EXTREMITY1% 1.1%
ARTHRALGIA0.9% 1.1%
RENAL FAILURE0.7% 1.1%
RENAL FAILURE ACUTE1.1% 0.7%
PARAESTHESIA0.5% 1.1%
CONDITION AGGRAVATED0.9% 1%
DEHYDRATION0.8% 1%
THROMBOCYTOPENIA0.7% 1%
OFF LABEL USE0.6% 1%
HAEMORRHAGE1% 0.6%
CLOSTRIDIUM DIFFICILE INFECTION0% 1%
ACUTE KIDNEY INJURY0% 1%
INSOMNIA0.9% 0.9%
DEATH0.9% 0.9%
FALL0.9% 0.8%
DECREASED APPETITE0.8% 0.9%
BACK PAIN0.9% 0.8%
OEDEMA PERIPHERAL0.9% 0.7%
HYPERSENSITIVITY0.9% 0.7%
CHOLECYSTITIS CHRONIC0.9% 0%
HYPERTENSION0.8% 0.8%
URTICARIA0.7% 0.8%
RESPIRATORY FAILURE0.8% 0.7%
GENERAL PHYSICAL HEALTH DETERIORATION0.8% 0.7%
ERYTHEMA0.6% 0.8%
HYPOAESTHESIA0.6% 0.8%
URINARY TRACT INFECTION0.5% 0.8%
PALPITATIONS0.8% 0.5%
NEUROPATHY PERIPHERAL0% 0.8%
NEUTROPENIA0% 0.8%
CLOSTRIDIUM DIFFICILE COLITIS0% 0.8%
CONSTIPATION0.7% 0.7%
GAIT DISTURBANCE0.6% 0.7%
TACHYCARDIA0.6% 0.7%
TREMOR0.7% 0.6%
ATRIAL FIBRILLATION0.7% 0.6%
INFECTION0.5% 0.7%
SYNCOPE0.7% 0.5%
CHOLELITHIASIS0.7% 0.5%
SOMNOLENCE0% 0.7%
SEPTIC SHOCK0% 0.7%
BRONCHITIS0.7% 0%
MUSCLE SPASMS0.6% 0.6%
FEELING ABNORMAL0.6% 0.6%
DYSPHAGIA0.6% 0.6%
CHILLS0.5% 0.6%
TOXICITY TO VARIOUS AGENTS0.5% 0.6%
PLEURAL EFFUSION0.5% 0.6%
MYALGIA0.5% 0.6%
INTERNATIONAL NORMALISED RATIO INCREASED0.6% 0.5%
ALANINE AMINOTRANSFERASE INCREASED0.4% 0.6%
PANCYTOPENIA0.4% 0.6%
ECONOMIC PROBLEM0.6% 0%
ASTHMA0.6% 0%
PATHOGEN RESISTANCE0% 0.6%
DYSGEUSIA0% 0.6%
SINUSITIS0.6% 0%
HAEMOGLOBIN DECREASED0% 0.6%
GALLBLADDER DISORDER0.6% 0%
ABORTION INCOMPLETE0.6% 0%
DIVERTICULITIS0% 0.6%
ABDOMINAL DISTENSION0% 0.6%
COLITIS0% 0.6%
CHEST DISCOMFORT0.6% 0%
CARDIAC FAILURE CONGESTIVE0.6% 0%
CROHN^S DISEASE0% 0.6%
ABDOMINAL DISCOMFORT0.5% 0.5%
CARDIAC ARREST0.5% 0.5%
GASTROINTESTINAL HAEMORRHAGE0% 0.5%
TOXIC ENCEPHALOPATHY0% 0.5%
DYSARTHRIA0% 0.5%
MUSCULAR WEAKNESS0% 0.5%
ASPARTATE AMINOTRANSFERASE INCREASED0% 0.5%
ANAPHYLACTIC REACTION0% 0.5%
ENCEPHALOPATHY0% 0.5%
FEBRILE NEUTROPENIA0% 0.5%
LOSS OF CONSCIOUSNESS0.5% 0%
HEART RATE INCREASED0.5% 0%
MYOCARDIAL INFARCTION0.5% 0%
ELECTROCARDIOGRAM QT PROLONGED0.5% 0%
NASOPHARYNGITIS0.5% 0%
DYSPEPSIA0.5% 0%
ANHEDONIA0.5% 0%
GASTROOESOPHAGEAL REFLUX DISEASE0.5% 0%
WEIGHT INCREASED0.5% 0%
CHRONIC OBSTRUCTIVE PULMONARY DISEASE0.5% 0%
HYPERHIDROSIS0.5% 0%
CEREBROVASCULAR ACCIDENT0.5% 0%
HYPOKALAEMIA0% 0.5%
BLOOD CREATININE INCREASED0.4% 0%
HAEMOPTYSIS0.4% 0%

New treatments are found every day. View current Azithromycin research studies and Flagyl clinical trials

1